Labcorp Holdings Inc. LH
309.64
0.69
0.22%
as of 25 Sep
- Market cap
- $21.9B
- P/E
- 25.4×
Follow LH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Labcorp Holdings Inc. (LH) P/B ratio
As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a P/B ratio of 2.9×. Over the past ten years it has ranged from 1.2× (March 2020) to 3.3× (March 2015); the current reading is higher than 97% of that period. That is below the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 2.4× | 1.34% |
| FY2024 | 2.4× | (7.11%) |
| FY2023 | 2.6× | 39.55% |
| FY2022 | 1.8× | (27.46%) |
| FY2021 | 2.5× | 40.92% |
| FY2020 | 1.8× | (4.11%) |
| FY2019 | 1.9× | 19.09% |
| FY2018 | 1.6× | (24.75%) |
| FY2017 | 2.1× | 1.66% |
| FY2016 | 2.1× | (2.73%) |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.7× | 5.65% |
| Mar 2026 | 2.5× | 3.89% |
| Dec 2025 | 2.4× | (11.72%) |
| Sep 2025 | 2.7× | 6.15% |
| 42 more quarters | Free account |
Against its own ten years
Low 1.2×
High 3.3×
Ten-year median
2.2×
Current reading's percentile
97
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| ICLR ICON PLC compare | 1.4× |
| RVTY Revvity Inc. compare | 2.3× |
| LH Labcorp Holdings Inc. | 2.9× |
| DGX Quest Diagnostics Incorporated compare | 3.4× |
| CRL Charles River Laboratories International, Inc. compare | 4.9× |
| TWST Twist Bioscience Corporation compare | 25.7× |
| MEDP Medpace Holdings, Inc. compare | 40.2× |
| MTD Mettler-Toledo International, Inc. compare | 2,372× |
| Diagnostics & Research industry median | 3.1× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on LH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement